Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration

Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration

Purpose To compare the efficacy of as-needed or variable dosing of intravitreal bevacizumab to continuous fixed-interval dosing in the management of neovascular age-related macular degeneration (AMD). Design Prospective, open-label, randomized clinical study. Methods One hundred twenty eyes of 120 p...

Full description

Saved in:
Bibliographic Details
Main Author: El-Mollayess, Georges M. (author)
Other Authors: Mahfoud, Ziyad (author), Schakal, Alexandre R. (author), Salti, Haytham I. (author), Jaafar, Dalida (author), Bashshura, Ziad F. (author)
Format: article
Published: 2012
Online Access:http://hdl.handle.net/10725/14180
https://doi.org/10.1016/j.ajo.2011.08.018
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.sciencedirect.com/science/article/pii/S000293941100643X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://hdl.handle.net/10725/14180
https://doi.org/10.1016/j.ajo.2011.08.018
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.sciencedirect.com/science/article/pii/S000293941100643X

Similar Items